Patricia Ohana

Technik-/Wissenschafts-/F&E-Leiter bei The Hebrew University of Jerusalem

Health Technology

Consumer Services

Aktive Positionen von Patricia Ohana

Unternehmen	Position	Beginn	Ende
The Hebrew University of Jerusalem	Technik-/Wissenschafts-/F&E-Leiter	-	-

Unternehmen	Position	Beginn	Ende
BioCancell Therapeutics, Inc. BioCancell Therapeutics, Inc. BiotechnologyHealth Technology BioCancell Therapeutics, Inc. is a development-stage biopharmaceutical company, which is focused on the discovery, development and commercialization of novel therapies for treating cancer-related diseases. The company's technology offers a safe and long-term treatment of cancer, with no adverse effects. The drug candidates developed by the company are targeted and its target is to selectively destroy the cancer cells without affecting healthy cells. BioCancell was founded on July 26, 2004 by Avraham Hochberg and is headquartered in Jerusalem, Israel.	Technik-/Wissenschafts-/F&E-Leiter	-	14.10.2010
	Corporate Officer/Principal	14.10.2010	-

International

Vereinigte Staaten	2
Israel	2

Operativ

Chief Tech/Sci/R&D Officer	2
Corporate Officer/Principal	1

Sektoral

Health Technology	2
Consumer Services	2

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Private Unternehmen	1
BioCancell Therapeutics, Inc. BioCancell Therapeutics, Inc. BiotechnologyHealth Technology BioCancell Therapeutics, Inc. is a development-stage biopharmaceutical company, which is focused on the discovery, development and commercialization of novel therapies for treating cancer-related diseases. The company's technology offers a safe and long-term treatment of cancer, with no adverse effects. The drug candidates developed by the company are targeted and its target is to selectively destroy the cancer cells without affecting healthy cells. BioCancell was founded on July 26, 2004 by Avraham Hochberg and is headquartered in Jerusalem, Israel.	Health Technology

Private Unternehmen

Health Technology